EZZ Life Science Holdings Limited (EZZ.AX)
AUD 1.53
(-2.24%)
AUD 1.53
(-2.24%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -18.89 Million AUD | -41.54% |
| 2023 | -13.35 Million AUD | -28.88% |
| 2022 | -10.36 Million AUD | -18.07% |
| 2021 | -8.77 Million AUD | -4.77% |
| 2020 | -8.37 Million AUD | -1923.5% |
| 2019 | -413.88 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -12.61 Million AUD | -21.8% |
| 2024 FY | -18.89 Million AUD | -41.54% |
| 2024 Q4 | -18.89 Million AUD | 0.0% |
| 2024 Q2 | -12.31 Million AUD | 2.41% |
| 2023 Q1 | -9.58 Million AUD | 7.47% |
| 2023 FY | -13.35 Million AUD | -28.88% |
| 2023 Q4 | -10.36 Million AUD | 24.42% |
| 2023 Q3 | -13.7 Million AUD | -43.79% |
| 2023 Q2 | -9.53 Million AUD | 0.55% |
| 2022 Q1 | -8.94 Million AUD | -1.96% |
| 2022 FY | -10.36 Million AUD | -18.07% |
| 2022 Q4 | -10.36 Million AUD | 1.0% |
| 2022 Q3 | -10.46 Million AUD | -17.32% |
| 2022 Q2 | -8.91 Million AUD | 0.3% |
| 2021 Q1 | -3.8 Million AUD | -21.21% |
| 2021 FY | -8.77 Million AUD | -4.77% |
| 2021 Q3 | -8.85 Million AUD | -140.58% |
| 2021 Q4 | -8.77 Million AUD | 0.89% |
| 2021 Q2 | -3.68 Million AUD | 3.41% |
| 2020 Q4 | -3.14 Million AUD | 1.0% |
| 2020 FY | -8.37 Million AUD | -1923.5% |
| 2020 Q1 | 413.88 Thousand AUD | 0.0% |
| 2020 Q3 | -3.17 Million AUD | 0.0% |
| 2019 FY | -413.88 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -2136.081% |
| Acrux Limited | -1.45 Million AUD | -1196.211% |
| Actinogen Medical Limited | -9.13 Million AUD | -106.958% |
| AnteoTech Limited | -5 Million AUD | -277.86% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -18.766% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -48.64% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -1824.307% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -51.434% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -936.348% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -254.623% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -2563.455% |
| Biome Australia Limited | -1.56 Million AUD | -1109.283% |
| Biotron Limited | -386.06 Thousand AUD | -4795.188% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 76.17% |
| BTC Health Limited | -2.02 Million AUD | -834.585% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -519.022% |
| CSL Limited | 15.76 Billion AUD | 100.12% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 86.155% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 89.672% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -204.552% |
| Dimerix Limited | -21.99 Million AUD | 14.064% |
| Hexima Limited | -2.22 Million AUD | -748.919% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -1426.051% |
| Immuron Limited | -11.48 Million AUD | -64.569% |
| Immutep Limited | -122.18 Million AUD | 84.533% |
| Imugene Limited | -91.56 Million AUD | 79.359% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -213.669% |
| Memphasys Limited | 4.13 Million AUD | 557.003% |
| Nanollose Limited | -96.22 Thousand AUD | -19540.171% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -10.558% |
| Noxopharm Limited | -2.31 Million AUD | -714.627% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -281.474% |
| Nyrada Inc. | -4.76 Million AUD | -296.252% |
| Orthocell Limited | -19.92 Million AUD | 5.149% |
| PharmAust Limited | -9.71 Million AUD | -94.55% |
| Patrys Limited | -2.24 Million AUD | -743.446% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | -7.492% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -198.849% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -85.962% |
| PYC Therapeutics Limited | -65.76 Million AUD | 71.262% |
| Race Oncology Limited | -17.18 Million AUD | -9.948% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | -1.743% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -456.478% |
| Starpharma Holdings Limited | -19.83 Million AUD | 4.706% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 82.136% |
| Tissue Repair Ltd | -16.44 Million AUD | -14.949% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 472.953% |